Markedly Enhanced Permeability and Retention Effects Induced by Photo-immunotherapy of Tumors

被引:224
作者
Sano, Kohei [1 ]
Nakajima, Takahito [1 ]
Choyke, Peter L. [1 ]
Kobayashi, Hisataka [1 ]
机构
[1] NCI, Mol Imaging Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
drug delivery; super-enhanced permeability and retention effect; photoimmunotherapy; nanomaterials; cancer imaging; cancer therapy; CONTRAST AGENTS; CARCINOMA; CHEMOTHERAPY; DELIVERY; THERAPY;
D O I
10.1021/nn305011p
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A major barrier to cancer treatment is the inability to deliver sufficient concentrations of drug to the tumor without incurring systemic toxicities. Nanomaterials are appealing because they can carry a large drug payload; however, tumor delivery is limited by modest leakage and retention in most tumors. We observed that after photoimmunotherapy (PIT), which is a light-mediated treatment based on an antibody photosensitizer conjugate, there was surprisingly high leakage of nanosized (10-200 nm) agents into the tumor bed. PIT rapidly Induced death in perivascular cancer cells, leading to immediate and dramatic increases in vascular permeability, resulting in up to 24-fold greater accumulation of nanomaterials within the PIT-treated tumor compared with controls, an effect termed "super-enhanced permeability and retention". In a treatment study, PIT followed by liposome-containing daunorubicin, DaunoXome (diameter 50 nm), resulted in greater survival In tumor-bearing mice than either PIT or DaunoXome alone. Thus, PIT greatly enhances delivery of nanosized reagents and thus holds promise to improve therapeutic responses.
引用
收藏
页码:717 / 724
页数:8
相关论文
共 27 条
[1]   Comparison of two blood pool contrast agents for 0.5-T MR angiography: Experimental study in rabbits [J].
Clarke, SE ;
Weinmann, HJ ;
Dai, EB ;
Lucas, AR ;
Rutt, BK .
RADIOLOGY, 2000, 214 (03) :787-794
[2]   Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles [J].
El-Sayed, Ivan H. ;
Huang, Xiaohua ;
El-Sayed, Mostafa A. .
CANCER LETTERS, 2006, 239 (01) :129-135
[3]   TUMOR MEASUREMENT IN THE NUDE-MOUSE [J].
EUHUS, DM ;
HUDD, C ;
LAREGINA, M ;
JOHNSON, FE .
JOURNAL OF SURGICAL ONCOLOGY, 1986, 31 (04) :229-234
[4]  
FORSSEN EA, 1992, CANCER RES, V52, P3255
[5]   US Food and Drug Administration approval: Panitumumab for epidermal growth factor receptor-expressing metestetic colorectal carcinoma with progression following fluropyrimidine-, oxelipletin-, and irinotecen-containing chemotherapy regimens [J].
Giusti, Ruthann M. ;
Shastri, Kaushikkumar ;
Pilaro, Anne M. ;
Fuchs, Chana ;
Cordoba-Rodriguez, Ruth ;
Koti, Kallappa ;
Rothmann, Mark ;
Men, Angela Yuxin ;
Zhao, Hong ;
Hughes, Monica ;
Keegan, Patricia ;
Weiss, Karen D. ;
Pazdur, Richard .
CLINICAL CANCER RESEARCH, 2008, 14 (05) :1296-1302
[6]   Guided delivery of polymer therapeutics using plasmonic photothermal therapy [J].
Gormley, Adam J. ;
Larson, Nate ;
Sadekar, Shraddha ;
Robinson, Ryan ;
Ray, Abhijit ;
Ghandehari, Hamidreza .
NANO TODAY, 2012, 7 (03) :158-167
[7]   Is Anticancer Drug Development Heading in the Right Direction? [J].
Hambley, Trevor W. .
CANCER RESEARCH, 2009, 69 (04) :1259-1261
[8]   The next frontier of molecular medicine: Delivery of therapeutics [J].
Jain, RK .
NATURE MEDICINE, 1998, 4 (06) :655-657
[9]   Nano-sized MRI contrast agents with dendrimer cores [J].
Kobayashi, H ;
Brechbiel, MW .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (15) :2271-2286
[10]   Macromolecular therapeutics in cancer treatment: The EPR effect and beyond [J].
Maeda, Hiroshi .
JOURNAL OF CONTROLLED RELEASE, 2012, 164 (02) :138-144